KU-60019 is a potent and selective ATM inhibitor. KU-60019 is 10-fold more effective than KU-55933 at blocking radiation-induced phosphorylation of key ATM targets in human glioma cells. As expected, KU-60019 is a highly effective radiosensitizer of human glioma cells. KU-60019 inhibits the DNA damage response, reduces AKT phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells Source summary: KU-60019 is a research-use small-molecule inhibitor for cell cycle studies; used in biochemical and molecular biology assays.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | ATM
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.